IL17A and infection: In this study, we found blockade of IL-17 signaling significantly attenuated the severity of P. aeruginosa airway infection by suppressing infection-induced cytokines, suggesting IL-17A may be used as a target of adjunctive therapy, in combination with antibiotics, to treat AECOPD patients with P. aeruginosa infection.